OR10A4 Antibody

What is OR10A4 and why is it significant for research?

OR10A4 (Olfactory receptor 10A4) is a member of the large family of G-protein-coupled receptors (GPCRs) involved in odorant signal recognition and transduction. Unlike most olfactory receptors that are primarily expressed in nasal tissues, OR10A4 is notable for its expression in the tongue, suggesting a potential dual role in both olfactory perception and taste sensation . This unique expression pattern makes OR10A4 an interesting target for researchers studying the molecular basis of chemosensory perception and the potential overlap between taste and smell pathways. The protein contains a 7-transmembrane domain structure typical of many neurotransmitter and hormone receptors, located in the cell membrane as a multi-pass protein .

What are the available types of OR10A4 antibodies and their applications?

OR10A4 antibodies are predominantly available as rabbit polyclonal antibodies targeting the C-terminal region (typically amino acids 245-273) of the human OR10A4 protein . These antibodies are available in various forms:

• Unconjugated antibodies for Western blotting, ELISA, and immunofluorescence

• Conjugated antibodies (e.g., PE-conjugated) for applications requiring fluorescent detection

• Validated antibodies with cross-reactivity to multiple species including human, cow, dog, guinea pig, horse, mouse, rabbit, and rat (with approximately 92-93% predicted reactivity across these species)

Primary applications include Western blotting (WB), ELISA, immunofluorescence (IF), and immunocytochemistry (ICC), with Western blotting being the most commonly validated application across different manufacturers .

How should OR10A4 antibodies be stored and handled for optimal results?

For optimal performance and longevity of OR10A4 antibodies, follow these research-validated storage and handling protocols:

• Short-term storage (up to 1 week): Maintain at 2-8°C in refrigeration

• Long-term storage: Store at -20°C in small aliquots to prevent freeze-thaw cycles

• Buffer conditions: Most commercial preparations are supplied in 1x PBS buffer with 0.09% (w/v) sodium azide and 2% sucrose

• Handling precautions: Avoid repeated freeze-thaw cycles as this can compromise antibody functionality

• Safety considerations: These products contain sodium azide, which should be handled by trained staff only as it is a poisonous and hazardous substance

Following these storage guidelines will help maintain antibody integrity and consistent experimental results throughout your research timeline.

What is the recommended dilution for OR10A4 antibodies in Western blotting?

For optimal results, researchers should:

• Begin with the manufacturer's recommended dilution

• Perform a dilution series experiment if working with new sample types

• Adjust antibody concentration based on signal intensity and background levels

• Validate specificity using appropriate positive and negative controls

Western blot analysis has successfully detected OR10A4 in human cell lines, confirming the utility of these antibodies for studying endogenous OR10A4 expression .

How can I optimize immunoprecipitation protocols for OR10A4 protein interactions?

Optimizing immunoprecipitation (IP) for OR10A4 requires careful consideration of this protein's membrane-bound nature and potential interaction partners. While standard IP protocols are listed in product information , the following modifications can enhance results specifically for OR10A4:

• Membrane protein extraction optimization:

  • Use specialized lysis buffers containing 1% NP-40 or 0.5% Triton X-100 with protease inhibitors

  • Consider mild sonication (3 × 5s pulses) to improve membrane protein solubilization

  • Extend lysis time to 30-45 minutes on ice with gentle agitation

• Pre-clearing optimization:

  • Extend pre-clearing time to 2 hours using protein A/G beads to reduce non-specific binding

  • Use 5% BSA as a blocking agent rather than standard protocols

• Antibody binding conditions:

  • Increase antibody incubation time to overnight at 4°C with gentle rotation

  • Consider using crosslinking methods (e.g., DSS or BS3) to permanently attach the antibody to beads, reducing antibody contamination

• Washing stringency balance:

  • Begin with lower stringency washes (PBS with 0.1% Triton X-100)

  • Gradually increase to higher stringency (PBS with 0.1-0.5% Triton X-100 and 150-300mM NaCl)

  • Monitor protein retention through each optimization step

These optimizations account for the multi-pass membrane nature of OR10A4 and should enhance the specificity and yield of OR10A4 immunoprecipitation for protein interaction studies.

What are the major challenges in detecting OR10A4 expression in tissue samples and how can they be overcome?

Detecting OR10A4 in tissue samples presents several research challenges due to its properties as a membrane-bound GPCR and its specific expression pattern. Key challenges and methodological solutions include:

• Low endogenous expression levels:

  • Implement signal amplification methods such as tyramide signal amplification

  • Use high-sensitivity detection systems with enhanced chemiluminescence

  • Consider RNA-based detection methods (RT-PCR, RNA-Seq) as complementary approaches

• Membrane protein extraction efficiency:

  • Optimize tissue homogenization using specialized tissue grinders

  • Use extraction buffers specifically formulated for membrane proteins

  • Consider sequential extraction protocols to enrich for membrane fractions

• Tissue-specific expression patterns:

  • Focus on tongue tissue where OR10A4 is predominantly expressed

  • Use precise microdissection techniques to isolate specific regions of interest

  • Include positive control tissues in experimental design

• Antibody specificity concerns:

  • Validate antibody specificity using OR10A4 overexpression systems

  • Include peptide competition assays to confirm binding specificity

  • Use multiple antibodies targeting different epitopes for confirmation

• Signal-to-noise optimization:

  • Extend blocking times (2+ hours) with 5% BSA or 5% milk

  • Optimize secondary antibody dilutions (typically 1:5000-1:10000)

  • Include additional washing steps and detergents like 0.05% Tween-20

These methodological optimizations can significantly improve the detection of OR10A4 in complex tissue samples, particularly from tongue specimens where the protein is endogenously expressed.

How can OR10A4 antibodies be effectively used to investigate potential roles in taste perception?

Given OR10A4's unique expression in the tongue and potential involvement in taste perception , specialized experimental approaches using OR10A4 antibodies can help elucidate its functional role:

• Co-localization studies with taste receptor markers:

  • Design dual immunofluorescence protocols using OR10A4 antibodies alongside established taste receptor markers (T1Rs, T2Rs)

  • Optimize fixation methods (4% PFA, 10-15 minutes) to preserve epitope accessibility

  • Use confocal microscopy with z-stack acquisition to analyze cellular co-localization

• Tissue-specific expression mapping:

  • Employ immunohistochemistry on tongue sections with attention to specific papillae types

  • Compare expression patterns across different taste zones (sweet, bitter, umami, sour, salt)

  • Correlate expression with functional taste bud subpopulations

• Taste cell isolation and OR10A4 characterization:

  • Use antibody-based cell sorting techniques to isolate OR10A4-positive cells

  • Analyze isolated populations for taste receptor co-expression and functional properties

  • Develop primary culture systems of OR10A4-positive cells for functional assays

• Functional taste perception assays:

  • Design calcium imaging experiments using OR10A4 antibodies for identifying responsive cells

  • Develop taste stimulation protocols targeting cells with OR10A4 expression

  • Correlate electrophysiological responses with OR10A4 expression patterns

These specialized approaches leverage OR10A4 antibodies within sophisticated experimental designs to investigate the protein's potential dual role in olfactory and taste perception systems, addressing a significant knowledge gap in chemosensory research.

How can I troubleshoot weak or non-specific signals when using OR10A4 antibodies?

When encountering weak signals or non-specific binding with OR10A4 antibodies, implement these systematic troubleshooting approaches:

• Weak signal optimization:

  • Adjust antibody concentration incrementally (try 1:500 instead of standard 1:1000)

  • Extend primary antibody incubation time to overnight at 4°C

  • Increase protein loading (50-75μg instead of standard 35μg)

  • Use signal enhancement systems compatible with your detection method

  • Try different blocking agents (5% BSA may work better than milk for membrane proteins)

• Non-specific binding reduction:

  • Implement more stringent washing protocols (increase wash times to 10 minutes, 5-6 washes)

  • Add 0.1% SDS to TBST wash buffer to reduce hydrophobic interactions

  • Use gradient SDS-PAGE (8-15%) for better protein separation

  • Pre-adsorb antibody with cell/tissue lysate from negative control samples

  • Consider using monovalent antibody fragments if available

• Validation strategies:

  • Test antibody on proven positive control samples (Jurkat, K562 cell lysates)

  • Include peptide competition controls to distinguish specific from non-specific signals

  • Compare multiple antibody lots or sources targeting different epitopes

  • Verify target expression using orthogonal methods (qPCR, RNA-Seq)

• Technical considerations:

  • Optimize transfer conditions for membrane proteins (use 0.2μm PVDF, extend transfer time)

  • Experiment with different membrane blocking times (1-3 hours)

  • Ensure fresh reagents, particularly detection substrates

  • Consider native vs. reducing conditions based on epitope accessibility

These systematic troubleshooting approaches address the common challenges encountered when working with membrane proteins like OR10A4 and should significantly improve both signal specificity and intensity.

What is the optimal protocol for Western blotting using OR10A4 antibodies?

The following optimized Western blotting protocol has been specifically designed for detecting OR10A4 using validated antibodies:

• Sample preparation:

  • Prepare cell lysates from target tissues (preferably tongue) or cell lines (Jurkat, K562)

  • Use RIPA buffer supplemented with protease inhibitors for efficient extraction

  • Load 35-50μg of total protein per lane for optimal detection

• Gel electrophoresis:

  • Use 10-12% SDS-PAGE gels for optimal separation near the 34-35 kDa range (calculated MW of OR10A4)

  • Include molecular weight markers covering the 25-50 kDa range

  • Run at 100V until samples enter resolving gel, then increase to 150V

• Transfer conditions:

  • Transfer to 0.2μm PVDF membrane (preferred over nitrocellulose for membrane proteins)

  • Use semi-dry transfer at 15V for 45 minutes or wet transfer at 30V overnight at 4°C

  • Verify transfer efficiency with reversible protein stain before blocking

• Blocking and antibody incubation:

  • Block membrane with 5% non-fat dry milk in TBST for 1 hour at room temperature

  • Dilute primary OR10A4 antibody 1:1000 in blocking buffer

  • Incubate with primary antibody overnight at 4°C with gentle agitation

  • Wash 4 × 5 minutes with TBST

• Detection:

  • Incubate with HRP-conjugated secondary antibody (1:5000) for 1 hour at room temperature

  • Wash 6 × 5 minutes with TBST

  • Develop using enhanced chemiluminescence reagents

  • Expose to X-ray film or use digital imaging system with incremental exposure times

Expected result: Detection of OR10A4 protein at approximately 34-35 kDa with minimal background signal when using validated cell lines as positive controls .

How can OR10A4 antibodies be used effectively in immunofluorescence studies?

For robust immunofluorescence detection of OR10A4 in cellular and tissue contexts, implement this specialized protocol:

• Sample preparation:

  • For cultured cells: Grow cells on poly-L-lysine coated coverslips to 70-80% confluence

  • For tissue sections: Prepare 5-8μm cryosections from fresh-frozen tissue or 4-6μm sections from paraffin-embedded samples

  • For paraffin sections: Perform heat-mediated antigen retrieval (10mM citrate buffer, pH 6.0)

• Fixation and permeabilization:

  • Fix samples with 4% paraformaldehyde for 15 minutes at room temperature

  • Permeabilize with 0.2% Triton X-100 in PBS for 10 minutes

  • For membrane proteins like OR10A4, consider milder permeabilization (0.1% saponin) to preserve membrane structure

• Blocking and antibody incubation:

  • Block with 5% normal serum (from secondary antibody host species) and 1% BSA in PBS for 1 hour

  • Dilute OR10A4 primary antibody 1:100-1:200 in blocking solution

  • Incubate overnight at 4°C in a humidified chamber

  • Wash 3 × 5 minutes with PBS

• Secondary antibody and counterstaining:

  • Incubate with fluorophore-conjugated secondary antibody (1:500) for 1 hour at room temperature

  • For PE-conjugated OR10A4 antibodies , skip the secondary antibody step

  • Wash 3 × 5 minutes with PBS

  • Counterstain nuclei with DAPI (1μg/ml) for 5 minutes

  • Mount with anti-fade mounting medium

• Imaging and analysis:

  • Use confocal microscopy for detailed subcellular localization

  • Employ appropriate excitation/emission settings for your fluorophore

  • Capture z-stack images for 3D reconstruction of membrane localization

  • Include no-primary antibody controls to assess non-specific binding

This protocol accommodates both direct detection using fluorophore-conjugated OR10A4 antibodies and traditional indirect immunofluorescence approaches, allowing flexible experimental design based on available reagents.

What controls should be included when validating OR10A4 antibody specificity?

Comprehensive validation of OR10A4 antibody specificity requires the following systematic controls:

• Positive controls:

  • Cell lines with confirmed OR10A4 expression (Jurkat, K562)

  • Tissue samples from tongue, where OR10A4 is endogenously expressed

  • Transiently transfected cells overexpressing OR10A4 (HEK293, CHO)

• Negative controls:

  • Cell lines with minimal OR10A4 expression (determined by RNA-seq databases)

  • Tissues where OR10A4 is not expressed (e.g., liver, kidney)

  • OR10A4 knockout or knockdown samples (siRNA, CRISPR)

• Technical controls:

  • No primary antibody control (secondary antibody only)

  • Isotype control (irrelevant rabbit IgG at equivalent concentration)

  • Pre-immune serum control (if available from antibody manufacturer)

• Peptide competition assay:

  • Pre-incubate OR10A4 antibody with excess immunizing peptide (10:1 molar ratio)

  • Run parallel assays with blocked and unblocked antibody

  • Specific signals should be significantly reduced or eliminated

• Cross-validation approaches:

  • Compare multiple OR10A4 antibodies targeting different epitopes

  • Correlate protein detection with mRNA expression data

  • Confirm size specificity with Western blotting (34-35 kDa)

These comprehensive validation controls provide multiple lines of evidence for antibody specificity, which is particularly important for GPCRs like OR10A4 that may have sequence similarity with other family members.

How can OR10A4 antibodies be used to investigate potential roles beyond olfaction?

OR10A4's expression in the tongue suggests functional roles beyond classical olfaction . OR10A4 antibodies enable several innovative research approaches to explore these non-canonical functions:

• Taste perception studies:

  • Use OR10A4 antibodies to identify and isolate OR10A4-positive taste cells

  • Perform co-localization studies with established taste receptor markers

  • Analyze calcium responses in OR10A4-positive cells following taste stimuli

  • Correlate OR10A4 expression with specific taste modalities (sweet, bitter, umami)

• Potential metabolic sensing roles:

  • Investigate OR10A4 expression in metabolic tissues (hypothalamus, gut)

  • Analyze expression changes during different metabolic states (fasting, feeding)

  • Study potential OR10A4 regulation by metabolic hormones (insulin, leptin)

• Developmental biology applications:

  • Track OR10A4 expression during taste bud development

  • Correlate expression with functional taste development milestones

  • Use OR10A4 as a marker for specific chemosensory cell lineages

• Comparative anatomy studies:

  • Compare OR10A4 expression patterns across species (human, cow, dog, etc.)

  • Correlate expression differences with dietary preferences and evolutionary adaptations

  • Analyze expression in specialized chemosensory structures across species

These approaches leverage OR10A4 antibodies to explore the protein's potential involvement in chemosensory integration between smell and taste, metabolic sensing, and evolutionary adaptations in chemosensory systems.

What are the latest methodological advances for studying OR10A4 protein interactions?

Recent methodological advances have enhanced our ability to study OR10A4 protein interactions using antibody-based approaches:

• Proximity labeling techniques:

  • BioID or TurboID fusion with OR10A4 followed by streptavidin pulldown

  • APEX2-based proximity labeling in OR10A4-expressing cells

  • Validation of proximity labeling hits using co-immunoprecipitation with OR10A4 antibodies

• Advanced microscopy approaches:

  • Super-resolution microscopy (STORM, PALM) for nanoscale organization

  • FRET/FLIM analysis using fluorescently labeled OR10A4 antibodies

  • Single-molecule tracking of OR10A4 in live cells using directly labeled antibody fragments

• Protein complex analysis:

  • Blue native PAGE followed by Western blotting with OR10A4 antibodies

  • Crosslinking mass spectrometry (XL-MS) coupled with OR10A4 immunoprecipitation

  • Size exclusion chromatography with antibody-based detection

• Functional interaction mapping:

  • Chemogenetic approaches using OR10A4 antibody-based cell sorting

  • Calcium imaging in identified OR10A4-positive cells following sensory stimulation

  • Correlation of OR10A4 expression with G-protein coupling preferences

These cutting-edge methodologies expand the experimental toolkit available for OR10A4 research, enabling more sophisticated analysis of its protein interactions, signaling pathways, and functional roles in chemosensation.

How do species differences in OR10A4 impact antibody selection for comparative studies?

The OR10A4 protein exhibits variable sequence conservation across species, with predicted reactivity ranging from 92-93% in non-human species compared to human OR10A4 . These differences necessitate careful antibody selection for comparative studies:

• Species reactivity considerations:

  • Available antibodies show predicted reactivity with cow (92%), dog (93%), guinea pig (92%), horse (93%), mouse (92%), rabbit (92%), and rat (92%)

  • Western blot validation is typically performed on human samples, requiring additional validation for cross-species applications

• Epitope conservation analysis:

  • The C-terminal region (amino acids 245-273) used for antibody generation may have varying conservation

  • Sequence alignment of this region across target species should be performed before antibody selection

  • Alternative epitopes may be considered for species with lower conservation in the C-terminal region

• Validation strategies for cross-species applications:

  • Perform Western blotting with positive control samples from each target species

  • Include appropriate negative controls (tissues not expressing OR10A4)

  • Consider peptide competition assays with species-specific peptides

  • Validate antibody specificity using recombinant OR10A4 from each species

• Technical adjustments for cross-species studies:

  • Optimize antibody concentration for each species (may require higher concentrations)

  • Adjust incubation times and conditions based on epitope accessibility

  • Consider using multiple antibodies targeting different epitopes for confirmation

These considerations ensure robust cross-species comparisons when studying OR10A4 expression and function across different animal models, contributing to broader understanding of OR10A4 evolution and specialization.

What are the most common pitfalls when using OR10A4 antibodies and how can they be avoided?

Researchers working with OR10A4 antibodies commonly encounter these challenges, which can be addressed through specific technical approaches:

• Membrane protein extraction difficulties:

  • Problem: Incomplete solubilization of OR10A4 from membrane fractions

  • Solution: Use specialized extraction buffers containing 1-2% SDS or 6-8M urea for complete denaturation, followed by dilution to reduce detergent concentration before immunoprecipitation

• Non-specific bands in Western blots:

  • Problem: Multiple bands observed beyond the expected 34-35 kDa size

  • Solution: Increase blocking time to 2 hours, use 5% BSA instead of milk, and include 0.1% SDS in wash buffers to reduce non-specific binding

• Inconsistent immunofluorescence results:

  • Problem: Variable staining patterns across experiments

  • Solution: Standardize fixation protocols (4% PFA, 15 minutes), optimize permeabilization (0.1% saponin for membrane proteins), and use directly conjugated antibodies to eliminate secondary antibody variability

• Low signal in low-expressing tissues:

  • Problem: Difficulty detecting OR10A4 in tissues with modest expression

  • Solution: Implement signal amplification methods (tyramide signal amplification), increase antibody concentration (1:500), and extend incubation time (48 hours at 4°C)

• Cross-reactivity with other olfactory receptors:

  • Problem: Potential recognition of structurally similar olfactory receptors

  • Solution: Perform peptide competition assays, include OR10A4 knockdown controls, and validate with multiple antibodies targeting different epitopes

These technical solutions address the most common experimental challenges with OR10A4 antibodies, improving reproducibility and confidence in research findings.

How can I optimize OR10A4 detection in challenging sample types?

Detecting OR10A4 in challenging sample types (fixed tissues, limited material, samples with high background) requires specialized optimization strategies:

• Formalin-fixed paraffin-embedded (FFPE) tissues:

  • Implement extended antigen retrieval (20-30 minutes in citrate buffer, pH 6.0)

  • Use high-concentration antibody (1:50-1:100)

  • Consider tyramide signal amplification systems

  • Pretreat sections with protein deglycosylation enzymes to unmask epitopes

• Samples with high auto-fluorescence:

  • Pretreat with sodium borohydride (0.1%, 10 minutes) to reduce background

  • Use far-red fluorophores that minimize autofluorescence interference

  • Implement spectral unmixing during confocal microscopy

  • Consider directly labeled OR10A4 antibodies with bright fluorophores

• Limited sample material:

  • Optimize protein extraction with sequential detergent extraction

  • Use capillary-based Western blot systems requiring minimal sample input

  • Implement whole-mount immunofluorescence for small tissue fragments

  • Consider in situ proximity ligation assay (PLA) for enhanced sensitivity

• Highly glycosylated samples:

  • Treat with PNGase F or other deglycosylation enzymes before analysis

  • Compare migration patterns before and after deglycosylation

  • Optimize sample buffer conditions (include reducing agents)

  • Consider native PAGE followed by Western blotting for complex samples

These optimizations enable reliable OR10A4 detection across diverse and challenging sample types, expanding the utility of OR10A4 antibodies for specialized research applications.

How should researchers interpret conflicting results between different OR10A4 antibodies?

When faced with discrepancies between different OR10A4 antibodies, implement this systematic interpretation framework:

• Epitope-based analysis:

  • Compare the exact epitope sequences targeted by each antibody

  • Assess whether epitopes might be differentially accessible in various experimental contexts

  • Consider post-translational modifications that might affect epitope recognition

  • Evaluate the potential for epitope masking in protein complexes

• Validation hierarchy establishment:

  • Prioritize results from antibodies with extensive validation documentation

  • Give greater weight to antibodies that have been validated against knockout/knockdown controls

  • Consider whether different antibodies might be detecting different isoforms or splice variants

  • Assess correlation between protein detection and mRNA expression data

• Technical reconciliation approaches:

  • Test all antibodies side-by-side under identical conditions

  • Perform peptide competition assays for all antibodies

  • Evaluate whether discrepancies are quantitative (signal intensity) or qualitative (localization/size)

  • Consider whether sample preparation methods differentially affect epitope accessibility

• Resolution strategies:

  • Use orthogonal methods (mass spectrometry, RNA-seq) to resolve conflicts

  • Generate tagged OR10A4 constructs for parallel validation

  • Implement CRISPR/Cas9 knockout controls to definitively assess specificity

  • Consult with antibody manufacturers regarding known limitations

This systematic approach transforms conflicting antibody results from an experimental problem into a scientific opportunity to gain deeper insights into OR10A4 biology, including potential isoforms, post-translational modifications, or context-dependent conformational states.